Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder
Status:
Suspended
Trial end date:
2024-01-31
Target enrollment:
Participant gender:
Summary
This is a non-inferiority randomized clinical trial that will compare slow release oral
morphine vs methadone as a second line oral treatment for opioid use disorder.
Phase:
Phase 3
Details
Lead Sponsor:
M. Eugenia Socias
Collaborators:
Canadian Institutes of Health Research (CIHR) Mayne Pharma International Pty Ltd Vancouver Foundation